Insights & Analysis

The FutureDX Blog

Deep dives on infectious disease diagnostics, molecular testing advances, AI in clinical science, regulatory updates, and global health — from our editorial team and invited contributors.

Featured Article

IVDR Implementation in 2026: What UK Diagnostic Manufacturers Must Do Now

Regulatory

3 min read · March 2026

IVDR Implementation in 2026: What UK Diagnostic Manufacturers Must Do Now

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026.

We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

All Articles

Latest from the Dx world

All AI & Data AMR Clinical Science Global Health NCS & Genomics Regulatory Technology

Whole Genome Sequencing in Routine NHS Microbiology: Where Are We Now?

NCS & Genomics

Mar 2026 · 3 min read

Whole Genome Sequencing in Routine NHS Microbiology: Where Are We Now?

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

Climate Change and Infectious Disease: What Diagnostics Must Prepare For

Global Health

Mar 2026 · 3 min read

Climate Change and Infectious Disease: What Diagnostics Must Prepare For

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

Sepsis Diagnostics in 2026: The Race Against Time in Emergency Settings

Clinical Science

Mar 2026 · 3 min read

Sepsis Diagnostics in 2026: The Race Against Time in Emergency Settings

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

AI in Clinical Microbiology: What 60% Adoption Really Means for NHS Labs

AI & Data

Mar 2026 · 3 min read

AI in Clinical Microbiology: What 60% Adoption Really Means for NHS Labs

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

Rapid AMR Detection: How Molecular Tools Are Transforming UK Stewardship

AMR

Mar 2026 · 3 min read

Rapid AMR Detection: How Molecular Tools Are Transforming UK Stewardship

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

CRISPR-Based Diagnostics: From Research Tool to Point-of-Care Platform

Technology

Mar 2026 · 3 min read

CRISPR-Based Diagnostics: From Research Tool to Point-of-Care Platform

The EU In Vitro Diagnostic Regulation (IVDR) is now fully in force, and UK manufacturers exporting into Europe face a dual compliance landscape — UKCA marking domestically and CE-IVD for European markets. Here is what your regulatory team needs to action before year-end 2026. <br/><br/> We break down the technical file requirements, the notified body bottleneck, and the practical steps to maintaining market access on both sides of the Channel — with expert input from speakers confirmed for FutureDX 2026.

1 2 →